The Common Sense Caucus supports NYC retirees in a legal battle against transitioning to a Medicare Advantage plan, highlighting a pivotal case for municipal commitment to retiree healthcare.

The U.S. Supreme Court is set to rule on the ACA’s mandate for health plans to provide preventive health services without cost-sharing. Discover the implications for U.S. healthcare policy and the stance of the AMA in this critical case.

Explore the challenges and legislative efforts in Ohio surrounding prior authorization and its impact on patient care, including a potential reform to simplify the process.

Exploring the 15-year journey of the Affordable Care Act, its impact on U.S. health insurance, and future challenges as subsidies near expiration in 2025.

President Trump's executive order delays Medicare drug price negotiations, favoring pharmaceutical companies and potentially increasing drug costs for the public.

Explore significant updates in the U.S. insurance industry related to prior authorization, including federal and state legislative shifts, and the deployment of AI technology.

Discover the latest changes in Medicare Advantage policies announced by CMS for 2026, highlighting new compliance standards and efforts to improve healthcare integration and quality.

Cobi Blumenfeld-Gantz testified before the Senate Finance Committee, discussing misleading marketing practices in Medicare Advantage plans, spotlighting the need for stricter regulatory oversight.

Explore recent U.S. Medicare policy changes including Trump's executive orders to lower healthcare costs and legislative advocacy to cover anti-obesity drugs, alongside market developments involving Humana and Cone Health.

The CMS final rule effective 2026 will modernize Medicare Advantage and Part D, enhancing drug coverage and establishing more robust regulatory frameworks.